Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KCNN4 | O15554 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7764290 | 0.83 | KCNN4 (0.43) | LMNAKCNN4MAPK1ALDH1A1TAAR1 | |
| SCHEMBL29280866 | 0.83 | MAPK1 (0.48) | LMNAKCNN4MAPK1ALDH1A1TAAR1 | |
| SCHEMBL8820311 | 0.83 | LMNA (0.41) | LMNAKCNN4MAPK1KDM4EMEN1 | |
| SCHEMBL15357624 | 0.81 | LMNA (0.44) | LMNAKCNN4MAPK1KDM4EMEN1 | |
| SCHEMBL11750519 | 0.81 | LMNA (0.41) | LMNAMEN1KMT2AALDH1A1GAA | |
| Hydrochloric Acid SCHEMBL27457472 | 0.81 | LMNA (0.42) | LMNAKCNN4MAPK1KDM4EMEN1 | |
| SCHEMBL6057047 | 0.79 | LMNA (0.45) | LMNAKCNN4MAPK1KDM4EMEN1 | |
| SCHEMBL22788269 | 0.79 | KCNN4 (0.40) | LMNAKCNN4MAPK1ALDH1A1TAAR1 | |
| SCHEMBL2238102 | 0.79 | KCNN4 (0.40) | LMNAKCNN4MAPK1ALDH1A1TAAR1 | |
| SCHEMBL3950657 | 0.79 | KCNN4 (0.40) | LMNAKCNN4MAPK1ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102047181-B | Photosensitive resin composition | ASAHI KASEI E MATERIALS CORP | 2013-01-23 | — | — | CN | disclosed |
| CN-102047181-A | Photosensitive resin composition | ASAHI KASEI E MATERIALS CORP | 2011-05-04 | — | — | CN | disclosed |
| US-20100256329-A1 | STEREOSELECTIVE ALTERNATING COPOLYMERIZATION OF EPOXIDE WITH CARBON DIOXIDE | THE UNIVERSITY OF TOKYO (JP) | 2010-10-07 | — | — | US | disclosed |
| US-7172855-B2 | Silver halide photographic light-sensitive material and package thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2007-02-06 | — | — | US | disclosed |
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | TAISHO PHARMACEUTICAL CO., LTD. | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | HCRTR2, MCHR1, MCHR2 | LMNA 3391/4885KCNN4 1683/4885MAPK1 2507/4885 |
| US-20100256329-A1 | STEREOSELECTIVE ALTERNATING COPOLYMERIZATION OF EPOXIDE WITH CARBON DIOXIDE | PCNA, HPD, TET3 | LMNA 3481/4885KCNN4 2645/4885MAPK1 3529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.